Sanofi criticised for multiple sclerosis manoeuvres
November 2, 2012Sales and Marketing Cancer, Lemtrada, MS, Sanofi
Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …
COPA-DATA appoints new UK managing director
November 2, 2012Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams
Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …
Novartis says Canada and Switzerland lift vaccines ban
November 2, 2012Manufacturing and Production Canada, Novartis, Switzerland, vaccines
A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …
NICE hails ‘breakthrough’ skin cancer treatments
November 2, 2012Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf
Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …
Meningitis probe extends to NECC sister company
November 1, 2012Manufacturing and Production NECC, ameridose, meningitis
A second compounding pharmacy has been drawn into the investigation into the meningitis outbreak that has killed 29 people in …
Mike Mallinson joins The Access Partnership
November 1, 2012Medical Communications, Sales and Marketing Mark Mallinson, The Access Partnership
Mike Mallinson has been appointed to lead communications firm The Access Partnership in the role of president. Mallinson is a …
GSK hit by European austerity again
November 1, 2012Sales and Marketing Europe, GSK, Q3, austerity
GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …
Novartis to build $500 million biotech facility in Singapore
November 1, 2012Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore
Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …
Inspired Science appoints principal medical writer
October 31, 2012Medical Communications, Sales and Marketing Inspired Science, Peter Levantis
Med comms firm Inspired Science has announced the appointment of Dr Peter Levantis as principal medical writer. In this newly …
Diabetes softens generics blow for Sanofi
October 30, 2012Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff
Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …
Lilly appoints new chief ethics and compliance officer and senior VP
October 30, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly
Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …
Canada latest country to suspend sales of Novartis vaccines
October 30, 2012Manufacturing and Production Canada, Novartis, vaccines
Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …
Shionogi and ViiV strike new HIV deal
October 30, 2012Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV
HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …
Pharmalink AB strengthens senior management
October 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB
Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …
Boehringer to increase production of Respimat inhaler
October 30, 2012Manufacturing and Production Boehringer Ingelheim, Respimat SMI, Soft Mist
Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …
Patheon buys softgel specialist Banner in $255m deal
October 30, 2012Manufacturing and Production Capsugel, Patheon, banner pharmacaps
Patheon has forged a deal to acquire gelatin capsule specialist Banner Pharmacaps for $255 million in a deal that boosts …
Teva’s CML drug approved
October 29, 2012Research and Development, Sales and Marketing FDA, Synribo, Teva
Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …
Almirall welcomes UCB head into Board of directors
October 29, 2012Manufacturing and Production, Research and Development, Sales and Marketing Almirall, Gerhard Mayr
Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …
EU countries suspend sales of Novartis flu vaccines
October 29, 2012Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines
Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …
The NHS revolution – one wave at a time
October 26, 2012Sales and Marketing CCGs, NHS, pharma-NHS partnerships
The first group of prospective Clinical Commissioning Groups (CCGs) will have to wait a little longer to hear if they …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
